Origo Biopharma is a Spanish pharmaceutical company founded in 2017 by entrepreneurs with extensive experience in discovery and development of pharmaceuticals.

Our know-how ranges from early medicinal chemistry stages to successful execution of late stage clinical trials leading to registration of novel pharmaceutical products.

We specialize on research and development of small molecules that address health disorders related to TGF-β signaling dysfunction, among these fibrosis and cancer.


The discovery and development of next generation therapeutic products for treatment of severe diseases linked to TGF-β.


To improve life quality and ultimately, contribute to the curing of people suffering from devastating medical conditions.

Meet the Management team

Ramon Bosser
CEO and Shareholder

Andrea Sáez

Begoña Pampín
CMC Leader

Lucía García Ledo
Project Manager

Lino Balo
R&D Chemist

Roberto Noya
Financial Administrative

Tony Senso
External CMC Consultant

Scientific Advisors

Cleveland Clinic, Ohio, USA 

Co-Director, Section for Inflammatory Bowel Diseases 

Director, Inflammatory Bowel Diseases Research 

Director, Advanced Inflammatory Bowel Diseases Fellowship Program

Department of Gastroenterology, Hepatology & Nutrition 

Digestive Diseases and Surgery Institute 


Florian Rieder

Head of Inflammatory Diseases, Hospital Clinic, Barcelona (Spain)





Julià Panés

Drug Discovery Consultant; President, Hay Drug Discovery Consulting, LLC.





Douglas Hay

Prof Respiratory Medicine

Professor of Respiratory Medicine and coordinator of the National Reference Centre for Rare Pulmonary Diseases at the Louis Pradel Hospital and the Claude Bernard University Lyon (Lyon, France)



Vincent Cottin

Senior Scientific Director, Alimentiv





Brian Feagan

Prof Respiratory Medicine

Interstitial Lung Disease Unit, Pulmonary Department, University Hospital of Bellvitge (Barcelona, Spain)





Maria Molina

Professor of medicine, Women’s Guild Lung Institute in the Department of Medicine at Cedars-Sinai Medical Center. Adjunct professor of Pathology at the University of Michigan Medical School. 



Cory Hogaboam

Board of Directors

Clara Campàs
Chair of the Board, Asabys Parners

Yolanda Falcón
Board Member, Xes Galicia

Ramon Bosser
Board member and CEO

Julio Castro-Palomino
Board member and co-founder

Carme Pampín Casal
Board member and co-founder